Bloom Burton & Co. Inc.

65 Front Street East, Suite 300
Toronto, ON
Canada M5S3A9

Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events.

Recent News

  • Bloom Burton & Co. Inc. Announces Holdings in NeuPath Health Inc.

    Toronto, Ontario--(Newsfile Corp. - November 25, 2022) - Bloom Burton & Co. Inc. announces that 1,000 compensation options (Options) of NeuPath Health Inc. expired unexercised on December 3, 2021, and combined with prior treasury issuances of common shares (Shares) of NeuPath Health, and the expiry of 66,250 Share purchase warrants (Warrants) resulted in a decrease of beneficial holdings to below 10% of the outstanding Shares.Prior to the expiry of the Options, Bloom Burton, beneficially owned 4,425,000 Shares, 1,000 Options and...

    2022-11-25 5:30 PM EST
  • Pieter Cullis Receives the 2022 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - September 30, 2022) -  Bloom Burton & Co. ("Bloom Burton") is pleased to announce Pieter Cullis, Co-Founder of Acuitas Therapeutics, as the recipient of the 2022 Bloom Burton Award. Pieter Cullis led the development of lipid nanoparticle (LNP) delivery systems for molecular therapeutics at Acuitas Therapeutics. The result of a lifetime of dedicated research driven by scientific curiosity, LNP delivery systems are a critical technology that help to accelerate, among other life-saving therapies, mRNA vaccine development....

    2022-09-30 7:27 AM EDT
  • Three Finalists Announced for the 2022 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Bloom Burton & Co. is pleased to announce the finalists for the 2022 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2022, in alphabetical order, are: Frank Baylis, Executive Chairman, and Kris Shah, President, Baylis Medical TechnologiesPieter Cullis, Co-Founder and Chairman, Acuitas Therapeutics Jan...

    2022-05-10 7:07 AM EDT
  • Bloom Burton & Co. Announces the 2022 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - January 25, 2022) - Bloom Burton & Co. ("Bloom Burton") is excited to announce the launch of the 2022 Bloom Burton Award and the Bloom Burton Award Gala event to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 29, 2022. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, investor or policy maker who made the greatest contribution to Canada's innovative healthcare industry in...

    2022-01-25 7:00 AM EST
  • The Bloom Burton Healthcare Lending Trust Named Winner in 2021 Canadian Hedge Fund Awards

    Toronto, Ontario--(Newsfile Corp. - October 20, 2021) - The Bloom Burton Healthcare Lending Trust (the "Fund") was recognized for the best 5-year track record in the private debt category at the 2021 Canadian Hedge Fund Awards (CHFA). Bloom Burton Investment Group Inc. is the manager of the Fund as well as the Bloom Burton Canadian Healthcare Fund LP and the Bloom Burton Canadian Healthcare (RSP) Fund, alternative investment funds that focus on investments...

    2021-10-20 7:00 AM EDT
  • Carl Hansen Receives the 2021 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - October 1, 2021) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Dr. Carl Hansen of AbCellera Biologics ("AbCellera") as the recipient of the 2021 Bloom Burton Award. From the outset of the COVID-19 pandemic, AbCellera moved from initial screening of blood samples to human clinical trials of its antibody treatment for COVID-19 in 90 days - a process that normally takes years. In the same year, AbCellera's COVID-19 drug, bamlanivimab, was partnered with...

    2021-10-01 9:48 AM EDT
  • Three Finalists Announced for the 2021 Bloom Burton Award

    Toronto, Ontario--(Newsfile Corp. - April 27, 2021) - Bloom Burton & Co. is pleased to announce the three finalists for the 2021 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year.The three finalists are, in alphabetical order:Daniel Durocher, PhD: Scientific Co-founder, Repare Therapeutics; Carl Hansen, PhD: Founder and CEO, AbCellera; andHamed Shahbazi: Chairman and CEO,...

    2021-04-27 9:00 AM EDT
  • Richardson Wealth and Bloom Burton & Co. Announce Strategic Alliance to Expand Wealth Solutions in Healthcare Sector

    Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its wholly owned subsidiary Richardson Wealth Limited ("Richardson Wealth") and Bloom Burton & Co. Inc. ("Bloom Burton"), two of Canada's premier independent financial services firms, have entered into a strategic alliance dedicated exclusively on the healthcare sector. This strategic alliance helps unlock growth potential for both firms. Richardson Wealth expands an already broad shelf of wealth solutions by providing advisors...

    2021-02-09 4:20 PM EST